| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2008;39:743.)
© 2008 American Heart Association, Inc.
Editorials |
From the Departments of Neurosurgery and Neurology, Mayo Clinic, Rochester, Minn.
Correspondence to David G. Piepgras, Mayo Clinic, Department of Neurologic Surgery, 200 First Street SW, Rochester, MN 55905, US. E-mail piepgras.david@mayo.edu
Key Words: endovascular treatment intracranial aneurysm
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
See related article, pages 899–904.
In the retrospective analysis of their experience in treating 173 patients with 202 unruptured intracranial aneurysms (UIAs) with endosaccular coiling over a 12 year span from 1992 through August 2004, Standhardt et al1 document treatment outcomes with low morbidity and mortality but highly variable efficacy relative to durable, complete aneurysm obliteration. Such has been the experience of other investigators.2 Although the reported data are of interest, numerous questions remain, including the comprehensive postprocedure assessment of morbidity and mortality, and risk of adverse outcomes compared to natural history.
In this series 48% of the aneurysms were incidentally discovered, and approximately 30% were "other" aneurysms in patients having experienced hemorrhage from another aneurysm, so-called Group II patients in the International Study of Unruptured Intracranial Aneurysms (ISUIA),3 and 14% were symptomatic due to mass effect (typically larger aneurysms). Nearly 44% of these aneurysms were small in size (<7 mm diameter), 37% of medium size (7 to 12 mm) and nearly 20% large to giant in dimension. About half of the aneurysms had a small neck (<4 mm in breadth) which is commonly regarded as optimal for endosaccular coiling assuming no complicating anatomy such as branches arising from the aneurysm base or conditions such as existence of intraluminal thrombus.
Relative to procedural risk, particularly as compared to those of craniotomy and aneurysm clipping, the results which these operators have achieved are excellent—mortality in 0.5% and permanent stroke morbidity in 3.5%, with only 1% ultimately sustaining permanent severe
Related Article:
Stroke 2008 39: 899-904.
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |